📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vita Therapeutics

1.1 - Company Overview

Vita Therapeutics Logo

Vita Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cell engineering therapies using induced pluripotent stem cells and CRISPR-based genome editing to correct genetic defects and regenerate healthy tissues. Offers VTA-100 for limb-girdle muscular dystrophy (LGMD2A), with autologous reprogramming of a patient’s blood cells and allogeneic universal iPSC lines from healthy donors engineered to evade the immune system.

Products and services

  • Cell Therapy: Develops treatments using iPSCs and CRISPR-based genome editing to correct genetic defects and regenerate healthy tissues in patients
  • VTA-100: Constructs a cell therapy program utilizing gene-corrected induced pluripotent stem cells to replace defective cells for limb-girdle muscular dystrophy (LGMD2A)
  • Allogeneic Approach: Engineers immune-evasive universal iPSC lines from healthy donors to treat multiple patients with the same therapy

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vita Therapeutics

Memometal Logo

Memometal

HQ: France Website
  • Description: Provider of surgical implants for orthopedic surgeries, designing, developing, manufacturing, and marketing these products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Memometal company profile →
Tornier Logo

Tornier

HQ: The Netherlands Website
  • Description: Provider of medical devices serving surgeons who treat musculoskeletal injuries and disorders, with a global focus.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tornier company profile →
Progentix Logo

Progentix

HQ: The Netherlands Website
  • Description: Provider of synthetic bone substitutes designed to accelerate bone healing through a novel microstructure, with offerings related to the spine, spinal medical devices, and minimally invasive surgery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Progentix company profile →
Zavation Logo

Zavation

HQ: United States Website
  • Description: Provider of medical device and biologic products for spinal surgeries from an employee-owned company, designing, developing, manufacturing and distributing solutions including eZspand® expandable lumbar interbody fusion device, Multitude Fiber, UnifuZe-P, Zavatrix – Viable Allograft, Cervical Allograft, and CoreLink DBM demineralized bone matrix to improve patient quality of life.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zavation company profile →
DePuy Synthes Logo

DePuy Synthes

HQ: United States Website
  • Description: Provider of orthopedic and medtech equipment supporting healing and restoring movement. Offerings span joint reconstruction, trauma, craniomaxillofacial, spinal surgery, and sports medicine, plus ASC capabilities, advanced case management, loaner programs, matrixrib care, and orthopaedic education through the Johnson & Johnson Institute.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DePuy Synthes company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vita Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vita Therapeutics

2.2 - Growth funds investing in similar companies to Vita Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vita Therapeutics

4.2 - Public trading comparable groups for Vita Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vita Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vita Therapeutics

What does Vita Therapeutics do?

Vita Therapeutics is a provider of cell engineering therapies using induced pluripotent stem cells and CRISPR-based genome editing to correct genetic defects and regenerate healthy tissues. Offers VTA-100 for limb-girdle muscular dystrophy (LGMD2A), with autologous reprogramming of a patient’s blood cells and allogeneic universal iPSC lines from healthy donors engineered to evade the immune system.

Who are Vita Therapeutics's competitors?

Vita Therapeutics's competitors and similar companies include Memometal, Tornier, Progentix, Zavation, and DePuy Synthes.

Where is Vita Therapeutics headquartered?

Vita Therapeutics is headquartered in United States.

How many employees does Vita Therapeutics have?

Vita Therapeutics has 1,000 employees 🔒.

When was Vita Therapeutics founded?

Vita Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Vita Therapeutics in?

Vita Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vita Therapeutics

Who are the top strategic acquirers in Vita Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Vita Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vita Therapeutics?

Top strategic M&A buyers groups and sectors for Vita Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vita Therapeutics's sector and industry vertical

Which are the top PE firms investing in Vita Therapeutics's sector and industry vertical?

Top PE firms investing in Vita Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vita Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vita Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vita Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vita Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vita Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vita Therapeutics?

The key public trading comparables and valuation benchmarks for Vita Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vita Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vita Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vita Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vita Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vita Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Vita Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vita Therapeutics

Launch login modal Launch register modal